MMS Holdings Inc. (MMS), a leading data-focused contract research organization (CRO), has announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an investment in the Company alongside MMS Founder and CEO, Dr. Uma Sharma, who will maintain a significant ownership interest. MMS is an award-winning, global, data-focused CRO supporting pharmaceutical and biotech companies. Latham & Watkins LLP represented Lindsay Goldberg in the transaction with a corporate deal team led by New York partners Paul Kukish and Eyal Orgad, with associates William Tevlin, Jack Welch, Josh Barkow, Saem Kim, Ben Bussmann, and Victoria Cappucci. Advice was also provided on healthcare regulatory matters by Washington, D.C. partner Stuart Kurlander and Washington, D.C. counsel Nicole Liffrig Molife, with associate Margaret Rote; on FDA regulatory matters by Washington, D.C. partner Ben Haas, with associate Seth Olson; on tax matters by Bay Area partner Katharine Moir and New York partner Eric Kamerman, with associate Lukas Kutilek; on private equity finance matters by New York partner Kendra Kocovsky, with associates Danielle Bernstein and Joshua Guerra; on data privacy matters by Bay Area partner Heather Deixler, with associate Lydia Lim; on benefits and compensation matters by Washington, D.C. partner Adam Kestenbaum and Houston counsel Krisa Benskin; on real estate matters by New York partner Michelle Kelban and New York counsel Shira Bressler, with associate Yerin Yang; on intellectual property matters by New York partner Jeffrey Tochner, with associate Sebastian Moss; on antitrust matters by Washington, D.C. partner Amanda Reeves and Brussels counsel Tomas Nilsson; on foreign direct investment (FDI) matters by Hamburg counsel Jana Dammann, with associate Helena Hofmann; on environmental matters by New York counsel David Langer; and on insurance matters by Los Angeles partner Drew Levin, with associate Harrison White.~~